HCKT

The Hackett Group, Inc.

63
Fundamentals65/ 100
Valuation52/ 100
Upside potential59/ 100
Risk potential17/ 100

HCKT's outlook is improving, though it still trails on the overall score.

MSFT

Microsoft Corporation

76
Fundamentals75/ 100
Valuation69/ 100
Upside potential75/ 100
Risk potential10/ 100

MSFT has the edge over HCKT overall, supported by stronger valuation and stronger modeled upside.

HCKT Fundamentals

MetricStatus
Under pressure
Strong
Stable
Stable

HCKT's profitability is currently strong, and its cash flow and balance sheet are stable, but its revenue is under pressure.

MSFT Fundamentals

MetricStatus
Healthy
Strong
Healthy
Strong

MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.

HCKT PE Valuation

CHEAPFAIREXPENSIVE29x58x87x116x
CHEAPFAIREXPENSIVE29x58x87x116x
LevelPEPriceVs current
Forward8.7x$13.44—
Cheap16x$11.45-15%
Current19x$13.44—
Fair21x$14.55+8.2%
Expensive39x$26.96+101%

Historical ranges are pointers, not guarantees.

HCKT's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 8.7x next year's earnings, in its cheap range.

MSFT PE Valuation

CHEAPFAIREXPENSIVE11x21x32x42x
CHEAPFAIREXPENSIVE11x21x32x42x
LevelPEPriceVs current
Forward25x$523—
Cheap27x$525+0.4%
Current27x$523—
Fair34x$652+25%
Expensive37x$711+36%

Historical ranges are pointers, not guarantees.

MSFT has the edge over HCKT in the historical PE scenario, which offers more potential upside but is not a forecast.

HCKT Forward outlook

MetricOutlook
Strongly improving
Growth
Stable
Improving
Limited
High

Analysts expect HCKT's earnings to grow and its profitability to improve, with its revenue holding steady.

MSFT Forward outlook

MetricOutlook
Improving
Strong growth
Strong growth
Stable
Moderate
High

Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.

HCKT Risk to reward

ScenarioChangePrice
Upside+25%$16.84
Downside-17%$11.12

Calculated from the latest close: $13.44 on Nov 12.

HCKT trails MSFT on modeled risk to reward, with less potential upside and more potential downside.

MSFT Risk to reward

ScenarioChangePrice
Upside+28%$671.86
Downside-10%$472.97

Calculated from the latest close: $523.00 on Nov 12.

MSFT has a better modeled risk to reward balance than HCKT, with more potential upside and less potential downside.

HCKT Earnings Per Share

Q4 2023: $1.24Q1 2024: $1.26Q2 2024: $1.25Q3 2024: $1.22Q4 2024: $1.06Q1 2025: $0.85Q2 2025: $0.60Q3 2025: $0.38Q4 2025: $0.47Q1 2026: $0.53Q2 2026: $0.65Q3 2026: $0.70Forward: $1.55
Q4 2023: $1.24Q1 2024: $1.26Q2 2024: $1.25Q3 2024: $1.22Q4 2024: $1.06Q1 2025: $0.85Q2 2025: $0.60Q3 2025: $0.38Q4 2025: $0.47Q1 2026: $0.53Q2 2026: $0.65Q3 2026: $0.70Forward: $1.55
QuarterTTM EPSYoY
Forward$1.55+121%
Q3 2026$0.70+84%
Q2 2026$0.65+8.3%
Q1 2026$0.53-38%
Q4 2025$0.47-56%
Q3 2025$0.38-69%
Q2 2025$0.60-52%
Q1 2025$0.85-33%
Q4 2024$1.06-15%

HCKT's earnings per share have fallen from their peak: $0.70 over the past year, against $1.47 in late 2022.

MSFT Earnings Per Share

Q4 2023: $11.05Q1 2024: $11.54Q2 2024: $11.80Q3 2024: $12.11Q4 2024: $12.41Q1 2025: $12.93Q2 2025: $13.64Q3 2025: $14.06Q4 2025: $15.99Q1 2026: $16.80Q2 2026: $17.95Q3 2026: $19.15Forward: $20.79
Q4 2023: $11.05Q1 2024: $11.54Q2 2024: $11.80Q3 2024: $12.11Q4 2024: $12.41Q1 2025: $12.93Q2 2025: $13.64Q3 2025: $14.06Q4 2025: $15.99Q1 2026: $16.80Q2 2026: $17.95Q3 2026: $19.15Forward: $20.79
QuarterTTM EPSYoY
Forward$20.79+8.6%
Q3 2026$19.15+36%
Q2 2026$17.95+32%
Q1 2026$16.80+30%
Q4 2025$15.99+29%
Q3 2025$14.06+16%
Q2 2025$13.64+16%
Q1 2025$12.93+12%
Q4 2024$12.41+12%

MSFT has the edge over HCKT on earnings, with more consistent year-over-year improvement.

HCKT Quarterly Revenue

Q4 2023: $72MQ1 2024: $77MQ2 2024: $78MQ3 2024: $80MQ4 2024: $79MQ1 2025: $78MQ2 2025: $79MQ3 2025: $73MQ4 2025: $76MQ1 2026: $69MQ2 2026: $69MQ3 2026: $70M
Q4 2023: $72MQ1 2024: $77MQ2 2024: $78MQ3 2024: $80MQ4 2024: $79MQ1 2025: $78MQ2 2025: $79MQ3 2025: $73MQ4 2025: $76MQ1 2026: $69MQ2 2026: $69MQ3 2026: $70M
QuarterRevenueYoY
Q3 2026$69.8M-4.5%
Q2 2026$69.3M-12%
Q1 2026$68.8M-12%
Q4 2025$75.8M-4.4%
Q3 2025$73.1M-8.4%
Q2 2025$78.9M+1.6%
Q1 2025$77.9M+0.9%
Q4 2024$79.2M+9.4%

HCKT's revenue is shrinking: $70M last quarter, down 4.5% from the same quarter a year ago.

MSFT Quarterly Revenue

Q4 2023: $62BQ1 2024: $61.9BQ2 2024: $64.7BQ3 2024: $65.6BQ4 2024: $69.6BQ1 2025: $70.1BQ2 2025: $76.4BQ3 2025: $77.7BQ4 2025: $81.3BQ1 2026: $82.9BQ2 2026: $90BQ3 2026: $92.3B
Q4 2023: $62BQ1 2024: $61.9BQ2 2024: $64.7BQ3 2024: $65.6BQ4 2024: $69.6BQ1 2025: $70.1BQ2 2025: $76.4BQ3 2025: $77.7BQ4 2025: $81.3BQ1 2026: $82.9BQ2 2026: $90BQ3 2026: $92.3B
QuarterRevenueYoY
Q3 2026$92.3B+19%
Q2 2026$90B+18%
Q1 2026$82.9B+18%
Q4 2025$81.3B+17%
Q3 2025$77.7B+18%
Q2 2025$76.4B+18%
Q1 2025$70.1B+13%
Q4 2024$69.6B+12%

MSFT has the edge over HCKT on sales, with more consistent year-over-year improvement.

HCKT Free Cash Flow

Q4 2023: $25MQ1 2024: $2MQ2 2024: $13MQ3 2024: $9MQ4 2024: $20MQ1 2025: $3MQ2 2025: $4MQ3 2025: $9MQ4 2025: $17MQ1 2026: −$7MQ2 2026: $13MQ3 2026: −$1M
Q4 2023: $25MQ1 2024: $2MQ2 2024: $13MQ3 2024: $9MQ4 2024: $20MQ1 2025: $3MQ2 2025: $4MQ3 2025: $9MQ4 2025: $17MQ1 2026: −$7MQ2 2026: $13MQ3 2026: −$1M
QuarterFree cash flowYoY
Q3 2026-$1.3M-115%
Q2 2026$12.6M+237%
Q1 2026-$7.5M-382%
Q4 2025$17.1M-13%
Q3 2025$9M-3.9%
Q2 2025$3.7M-71%
Q1 2025$2.7M+44%
Q4 2024$19.6M-21%

HCKT usually generates cash, though not every quarter: the latest was −$1M, but it generated $21M over the past year.

MSFT Free Cash Flow

Q4 2023: $9.1BQ1 2024: $21BQ2 2024: $23.3BQ3 2024: $19.3BQ4 2024: $6.5BQ1 2025: $20.3BQ2 2025: $25.6BQ3 2025: $25.7BQ4 2025: $5.9BQ1 2026: $15.8BQ2 2026: $19.6BQ3 2026: $18.6B
Q4 2023: $9.1BQ1 2024: $21BQ2 2024: $23.3BQ3 2024: $19.3BQ4 2024: $6.5BQ1 2025: $20.3BQ2 2025: $25.6BQ3 2025: $25.7BQ4 2025: $5.9BQ1 2026: $15.8BQ2 2026: $19.6BQ3 2026: $18.6B
QuarterFree cash flowYoY
Q3 2026$18.6B-27%
Q2 2026$19.6B-23%
Q1 2026$15.8B-22%
Q4 2025$5.9B-9.3%
Q3 2025$25.7B+33%
Q2 2025$25.6B+9.6%
Q1 2025$20.3B-3.2%
Q4 2024$6.5B-29%

MSFT has the edge over HCKT on cash flow, with stronger typical year-over-year growth.

HCKT Total Shares

Q4 2023: 28MQ1 2024: 28MQ2 2024: 28MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 28MQ3 2025: 28MQ4 2025: 28MQ1 2026: 25MQ2 2026: 25MQ3 2026: 25M
Q4 2023: 28MQ1 2024: 28MQ2 2024: 28MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 28MQ3 2025: 28MQ4 2025: 28MQ1 2026: 25MQ2 2026: 25MQ3 2026: 25M
PeriodChange %Net change
Quarterly-0.8%-213K shares
1 year-9.6%-2.7M shares
3 years-10%-2.9M shares
5 years-24%-7.9M shares
Available history-23%-7.5M shares

HCKT has the edge over MSFT on shareholder dilution, with a more favorable share count trend.

MSFT Total Shares

Q4 2023: 7.5BQ1 2024: 7.5BQ2 2024: 7.5BQ3 2024: 7.5BQ4 2024: 7.5BQ1 2025: 7.5BQ2 2025: 7.5BQ3 2025: 7.5BQ4 2025: 7.5BQ1 2026: 7.4BQ2 2026: 7.5BQ3 2026: 7.4B
Q4 2023: 7.5BQ1 2024: 7.5BQ2 2024: 7.5BQ3 2024: 7.5BQ4 2024: 7.5BQ1 2025: 7.5BQ2 2025: 7.5BQ3 2025: 7.5BQ4 2025: 7.5BQ1 2026: 7.4BQ2 2026: 7.5BQ3 2026: 7.4B
PeriodChange %Net change
Quarterly-0.1%-7M shares
1 year-0.3%-20M shares
3 years-0.2%-16M shares
5 years-1.6%-121M shares
Available history-3.2%-245M shares

MSFT has 7.4B diluted shares, about the same as a year ago.

HCKT Net Leverage

Q4 2023: 0.2xQ1 2024: 0.3xQ2 2024: 0.1xQ3 2024: 0.2xQ4 2024: -0.1xQ1 2025: 0.2xQ2 2025: 0.4xQ3 2025: 1.1xQ4 2025: 2.0xQ1 2026: 2.2xQ2 2026: 1.8xQ3 2026: 1.9x
Q4 2023: 0.2xQ1 2024: 0.3xQ2 2024: 0.1xQ3 2024: 0.2xQ4 2024: -0.1xQ1 2025: 0.2xQ2 2025: 0.4xQ3 2025: 1.1xQ4 2025: 2.0xQ1 2026: 2.2xQ2 2026: 1.8xQ3 2026: 1.9x
QuarterNet LeverageStatus
Q3 20261.9xHealthy
Q2 20261.8xHealthy
Q1 20262.2xModerate
Q4 20252.0xModerate
Q3 20251.1xHealthy
Q2 20250.4xVery low
Q1 20250.2xVery low
Q4 2024-0.1xNet Cash

HCKT's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.1 years a year ago.

MSFT Net Leverage

Q2 2026: 0.1xQ3 2026: 0.1x
Q2 2026: 0.1xQ3 2026: 0.1x
QuarterNet LeverageStatus
Q3 20260.1xVery low
Q2 20260.1xVery low

MSFT has the edge over HCKT on leverage, with a lower net debt burden relative to earnings.

HCKT Weekly Momentum

MetricValueStatus
RSI59.5Neutral
Stochastic84.5Overbought

HCKT's weekly RSI is 60 (neutral) and its Stochastic is 84 (overbought).

MSFT Weekly Momentum

MetricValueStatus
RSI62.1Neutral
Stochastic68.0Neutral

MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).

HCKT PE vs Technology Sector

MetricHCKTSector medianRelative
PE19x28x31% below
PE %38353 pts above

HCKT has the edge over MSFT on valuation relative to its sector.

MSFT PE vs Technology Sector

MetricMSFTSector medianRelative
PE27x28x2% below
PE %163519 pts below

MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.

HCKT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$11.913% above
20 week MA$11.220% above
50 week MA$13.31% above
100 week MA$19.029% below
200 week MA$21.036% below

HCKT has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 36% below its 200-week average.

MSFT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$524.70.3% below
20 week MA$484.87.9% above
50 week MA$446.917% above
100 week MA$453.815% above
200 week MA$411.527% above

MSFT has the edge over HCKT on trend strength, trading above more of its moving averages.

HCKT Yearly ROI

YearStart priceEnd priceROI
2020$15.9$14.0-12%
2021$14.0$20.7+47%
2022$20.7$20.5-0.8%
2023$20.5$22.8+11%
2024$22.8$30.9+36%
2025$30.9$20.0-35%
2026 YTD$20.0$13.4-33%

HCKT has finished lower in three of the last six years. It's down 33% so far in 2026.

MSFT Yearly ROI

YearStart priceEnd priceROI
2020$159.0$222.8+40%
2021$222.8$334.7+50%
2022$334.7$238.7-29%
2023$238.7$376.0+58%
2024$376.0$430.5+14%
2025$430.5$487.7+13%
2026 YTD$487.7$523.0+7.2%

MSFT has the edge over HCKT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key